杨贵妃传媒視頻

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 杨贵妃传媒視頻 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 21 2022

Full Issue

Merck Drug Sees Failures In Treating Head And Neck Cancer

Keytruda, a cancer therapy drug from Merck, failed to show improvements in head and neck cancer patients' event-free survival times. Physicians joining unions, nurse burnout, remote-work for nurses, rising health industry profit projections, and more are also in the industry news.

Merck & Co Inc said on Wednesday its cancer therapy Keytruda failed to meet the main goal of a late-stage trial testing it in patients with head and neck cancer. The company said Keytruda, its blockbuster cancer drug, in combination with chemoraditation therapy showed improvement in event-free survival, or the period of time a patient remains free of complications compared to a placebo. (7/20)

In news on health worker matters 鈥

Dr. Monique Hedmann, a family medicine resident at Harbor-University of California, Los Angeles Medical Center in West Carson, works with patients from 8 a.m. to 5 p.m. But her day doesn't end there. (Christ, 7/20)

Many people may be moving on from Covid,聽but nurses certainly aren鈥檛 鈥斅燼nd as the latest聽variant sweeps the US, the mental stresses on the profession have reached new highs.聽A survey of 2,500 nurses聽released Wednesday finds that 64% are looking to leave the health-care profession, a nearly 40% increase from a similar survey a year ago. Three-quarters of those surveyed said they鈥檝e experienced burnout since the pandemic began and half said they had experienced feelings of trauma, extreme stress or PTSD.聽(Johnson, 7/20)

Burned out and fed up with their work conditions, nurses are leaving the bedside in droves, leaving empty positions and for-hire signs lingering in hospitals and clinics around the country. (Palmer, 7/21)

On other industry developments 鈥

Health care profits will rise significantly over the next few years, according to a new McKinsey & Company estimate 鈥斅爁urther evidence that providers and payers are doing just fine in the wake of the pandemic. (Owens, 7/20)

Apple Inc. published a nearly 60-page report Wednesday outlining all its health features and partnerships with medical institutions, arguing that such offerings are key to the tech giant鈥檚 future. The company pointed to its breadth of existing services -- from sleep monitoring and fitness classes to atrial-fibrillation detection and cycle tracking -- and promised to build on that foundation. Chief Operating Officer Jeff Williams, who oversees Apple鈥檚 health endeavors, said in a statement attached to the report that the company will continue to innovate in 鈥渟cience-based technology.鈥澛(Gurman, 7/20)

A Swedish non-profit organization focused on improving the mental-well being of young adults has attracted 100 million euros ($101 million) in funding from its founders, Annika Sten Parson and Par-Jorgen Parson. The Inner Foundation was set up by the husband-and-wife duo this year and has already made a number of investments including Meela, a platform offering personalized therapy for women, and StrongMinds, a non-profit for treating depression in sub-Saharan Africa. (Liman, 7/21)

Biogen Inc (BIIB.O) on Wednesday tried to assuage investor worries by laying out a plan for its Alzheimer's disease drug being developed with Eisai Co Ltd (4523.T) and promising to draw lessons from the setbacks to its treatment Aduhelm. Biogen also disclosed that it had agreed to pay $900 million to resolve a whistleblower lawsuit accusing it of paying doctors kickbacks to prescribe multiple sclerosis drugs. The case had been set to go on trial next week in Boston. It did not admit wrongdoing. (Mishra, 7/20)

After a decade of legal squabbling, Biogen has agreed in principle to pay $900 million to settle a lawsuit filed by a former employee who alleged the company paid kickbacks to hundreds of physicians to boost sales of its multiple sclerosis drugs. (Silverman, 7/20)

Providence, a Washington-based not-for-profit health system, is shrinking its executive team and streamlining some functions as it faces operational challenges. (Hudson, 7/20)

Also: how the health care system stymied one couple's quest for autism care 鈥

KHN: 鈥楽o Rudderless鈥: A Couple鈥檚 Quest For Autism Treatment For Their Son Hits Repeated Obstacles

When Sebastian Rios was a toddler, he hardly talked. 鈥淒on鈥檛 worry,鈥 his pediatrician told Amparo and Victor Rios, Sebastian鈥檚 parents. Kids who grow up in households in which both Spanish and English are spoken are sometimes slower to develop language skills, she said. Plus, Sebastian was developing well in other ways: When he was just 18 months old, for example, he could identify the magnetized letters of the alphabet on the refrigerator at their home in Bronxville, a short train ride north of New York City. (Andrews, 7/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, June 1
  • Friday, May 29
  • Thursday, May 28
  • Wednesday, May 27
  • Tuesday, May 26
  • Friday, May 22
More Morning Briefings
RSS Feeds
  • 杨贵妃传媒視頻
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF